LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Historical Holders from Q3 2015 to Q1 2020

Type / Class
Debt / NOTE 0.750% 8/1
All holders as of 31 Mar 2020
Q1 2020
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Period Principal Value Change Price Investors
2020 Q1 0 $0 -$3,882 0
2019 Q3 39 $3,882 -$39,777,118 $99.54 1
2019 Q2 26,328,000 $39,781,000 -$2,032,019 $1.51 5
2019 Q1 27,464,000 $45,945,000 -$64,040 $1.67 5
2018 Q4 27,461,000 $49,776,000 -$361,984,202 $1.81 6
2018 Q3 127,907,000 $453,455,000 -$195,070,770 $3.65 12
2018 Q2 181,116,000 $498,208,000 -$114,297,457 $2.75 12
2018 Q1 229,681,000 $503,037,000 -$8,237,722 $2.19 17
2017 Q4 243,307,000 $444,694,000 +$3,644,154 $1.83 23
2017 Q3 241,457,000 $440,973,000 -$93,512 $1.82 25
2017 Q2 242,680,000 $402,344,000 +$4,745,433 $1.66 25
2017 Q1 244,180,000 $364,402,000 +$6,247,247 $1.49 26
2016 Q4 241,400,000 $349,770,000 -$4,791,291 $1.45 24
2016 Q3 244,297,000 $357,451,000 -$2,220,426 $1.46 25
2016 Q2 242,690,000 $406,052,000 -$4,247,849 $1.67 24
2016 Q1 245,697,000 $373,336,000 -$1,423,530 $1.52 22
2015 Q4 245,621,600 $382,007,000 +$2,451,786 $1.55 22
2015 Q3 241,761,170 $314,220,141 +$282,556,141 $1.3 25